These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26194185)

  • 1. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.
    Ogura K; Fujiwara T; Yasunaga H; Matsui H; Jeon DG; Cho WH; Hiraga H; Ishii T; Yonemoto T; Kamoda H; Ozaki T; Kozawa E; Nishida Y; Morioka H; Hiruma T; Kakunaga S; Ueda T; Tsuda Y; Kawano H; Kawai A
    Cancer; 2015 Nov; 121(21):3844-52. PubMed ID: 26194185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
    Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
    Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
    Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
    Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
    J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms for predicting overall survival and cancer-specific survival of chondroblastic osteosarcoma patients.
    Gao Z; Zhou S; Song H; Wang Y; He X
    J Surg Oncol; 2020 Dec; 122(8):1676-1684. PubMed ID: 32862456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
    Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
    Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of nomogram to predict distant metastasis in osteosarcoma: a retrospective study.
    Lu S; Wang Y; Liu G; Wang L; Wu P; Li Y; Cheng C
    J Orthop Surg Res; 2021 Mar; 16(1):231. PubMed ID: 33785046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Delaloge S; Gonzalez-Angulo AM; Andre F; Hess KR; Buzdar AU; Garbay JR; Spielmann M; Mathieu MC; Symmans WF; Wagner P; Atallah D; Valero V; Berry DA; Hortobagyi GN
    J Clin Oncol; 2005 Nov; 23(33):8331-9. PubMed ID: 16293864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nomogram for predicting 5-year overall survival in Chinese patients with high-grade osteosarcoma.
    Yao Z; Tan Z; Yang J; Yang Y; Wang C; Chen J; Zhu Y; Wang T; Han L; Zhu L; Yang Z
    Sci Rep; 2021 Sep; 11(1):17728. PubMed ID: 34489489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for specific survival in osteosarcoma patients less than 60 years old: a population-based study.
    Zhao J; Jiao J; Su Y; Mu L
    J BUON; 2021; 26(5):2097-2105. PubMed ID: 34761622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
    Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
    Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of Nomograms to Assess Risk Factors and Overall Survival Prediction for Lung Metastasis in Young Patients with Osteosarcoma: A SEER-Based Study.
    Liu Z; Li G; Liu H; Zhu J; Wang D
    Int J Clin Pract; 2022; 2022():8568724. PubMed ID: 36380749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
    Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
    Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world impact of chemotherapy on overall survival in craniomaxillofacial osteosarcoma.
    Li YH; Zheng L; Chen GC; Zhang YM; Xu YZ; Huang YF
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101807. PubMed ID: 38431082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
    Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
    Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
    Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A
    Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.